• BCN Peptides R&D on Lysosomal Storage Diseases

    March 20, 2017

    BCN Peptides  is working in a research program having as therapeutic target  Lysosomal Storage diseases, a group of  rare inherited metabolic disorders that result from defects in lysosomal function.

    The project, enclosed in “Nuclis d’Innovació Tecnològica” program from ACCIÒ, is cofinanced with the European Union FEDER funds.